当前位置:首页 - 行情中心 - 尔康制药(300267) - 财务分析

尔康制药

(300267)

  

流通市值:67.56亿  总市值:97.97亿
流通股本:14.22亿   总股本:20.63亿

尔康制药(300267)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.09亿元,每股收益0.01元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益395931.63万元,未分配利润79938.18万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产495948.96万元,负债100017.34万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入247,387,142.021,165,761,300.561,006,423,651.81681,881,688.38
营业总成本241,298,499.461,164,383,715.31985,154,942.51656,655,615.53
其他经营收益
营业利润10,259,474.29-365,034,739.0234,268,975.5232,112,145.26
利润总额10,238,525.54-367,816,058.7830,750,162.6832,053,479.38
净利润9,431,220.1-399,311,259.9127,110,714.4528,810,557.54
每股收益
其他综合收益-25,060,678.8-33,376,075.86-17,720,724.55-15,845,203.45
综合收益总额-15,629,458.7-432,687,335.779,389,989.912,965,354.09
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计1,919,148,658.081,788,564,901.241,774,063,309.931,615,999,351.77
非流动资产:
非流动资产合计3,040,340,952.723,072,459,344.963,428,609,658.33,433,891,528.96
资产总计4,959,489,610.84,861,024,246.25,202,672,968.235,049,890,880.73
流动负债:
流动负债合计916,906,089.4802,726,936.71692,305,389.92533,867,935.14
非流动负债:
非流动负债合计83,267,263.8784,242,211.9498,327,822.11100,574,984.12
负债合计1,000,173,353.27886,969,148.65790,633,212.03634,442,919.26
所有者权益(或股东权益):
归属于母公司股东权益合计4,022,178,265.14,034,293,235.184,469,596,922.144,469,540,895.52
股东权益合计3,959,316,257.533,974,055,097.554,412,039,756.24,415,447,961.47
负债和股东权益合计4,959,489,610.84,861,024,246.25,202,672,968.235,049,890,880.73
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计263,400,613.211,492,447,126.221,200,091,914.04805,749,020.76
经营活动现金流出小计273,318,755.061,234,762,154.91988,407,066.69759,906,773.23
经营活动产生的现金流量净额-9,918,141.85257,684,971.31211,684,847.3545,842,247.53
投资活动产生的现金流量:
投资活动现金流入小计170,338,917.271,115,513,273.71744,694,174.37344,066,779.96
投资活动现金流出小计204,797,831.21,243,980,195.38932,779,667.07449,007,926.19
投资活动产生的现金流量净额-34,458,913.93-128,466,921.67-188,085,492.7-104,941,146.23
筹资活动产生的现金流量:
筹资活动现金流入小计355,750,000949,937,821692,587,821410,000,000
筹资活动现金流出小计313,068,556.69981,477,007.85725,728,061.56475,915,412.21
筹资活动产生的现金流量净额42,681,443.31-31,539,186.85-33,140,240.56-65,915,412.21
汇率变动对现金及现金等价物的影响-545,998.75-3,364,598.62-2,347,103.42-1,555,462.31
现金及现金等价物净增加额-2,241,611.2294,314,264.17-11,887,989.33-126,569,773.22
期末现金及现金等价物余额581,981,677.73584,223,288.95478,021,035.45363,339,251.56
补充资料:
现金及现金等价物的净增加额-94,314,264.17--126,569,773.22
TOP↑